Viewing StudyNCT00000749



Ignite Creation Date: 2024-05-05 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000749
Status: COMPLETED
Last Update Posted: 2012-10-30
First Post: 1999-11-02

Brief Title: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 CHO BIOCINE in MF59 Emulsion Versus the Emulsion Control Three Injections at 0 1 and 6 Months
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV Preventive Vaccine View
Vaccines Synthetic View
HIV Envelope Protein gp120 View
AIDS Vaccines View
HIV Seronegativity View